Preliminary safety data from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or without bevacizumab (B) in patients (pts) with gastric or oesophagogastric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback